This site displays a prototype of a “Web 2.0” version of the daily
Federal Register. It is not an official legal edition of the Federal
Register, and does not replace the official print version or the official
electronic version on GPO’s govinfo.gov.
The documents posted on this site are XML renditions of published Federal
Register documents. Each document posted on the site includes a link to the
corresponding official PDF file on govinfo.gov. This prototype edition of the
daily Federal Register on FederalRegister.gov will remain an unofficial
informational resource until the Administrative Committee of the Federal
Register (ACFR) issues a regulation granting it official legal status.
For complete information about, and access to, our official publications
and services, go to
About the Federal Register
on NARA's archives.gov.
The OFR/GPO partnership is committed to presenting accurate and reliable
regulatory information on FederalRegister.gov with the objective of
establishing the XML-based Federal Register as an ACFR-sanctioned
publication in the future. While every effort has been made to ensure that
the material on FederalRegister.gov is accurately displayed, consistent with
the official SGML-based PDF version on govinfo.gov, those relying on it for
legal research should verify their results against an official edition of
the Federal Register. Until the ACFR grants it official status, the XML
rendition of the daily Federal Register on FederalRegister.gov does not
provide legal notice to the public or judicial notice to the courts.
Notice
Enter a search term or FR citation e.g.
88 FR 38230 FR 78782024-13208USDA09/05/24RULE0503-AA39SORN
Choosing an item from
full text search results
will bring you to those results. Pressing enter in the search box
will also bring you to search results.
Choosing an item from
suggestions
will bring you directly to the content.
Date and Time: The public conference will be held on March 19 and 20, 2012, from 9 a.m. to 4:30 p.m.
Table of Contents
Enhanced Content - Table of Contents
This table of contents is a navigational tool, processed from the
headings within the legal text of Federal Register documents.
This repetition of headings to form internal navigation links
has no substantive legal effect.
Document page views are updated periodically throughout the day and are
cumulative counts for this document. Counts are subject to sampling,
reprocessing and revision (up or down) throughout the day.
Page views
50
as of
08/13/2026 at 10:15 am EDT
Other Formats
Enhanced Content - Other Formats
This document is also available in the following formats:
This PDF is FR Doc. 2012-1887 as it appeared on Public Inspection on
01/27/2012 at 8:45 am.
If you are using public inspection listings for legal research, you
should verify the contents of the documents against a final, official
edition of the Federal Register. Only official editions of the
Federal Register provide legal notice of publication to the public and judicial notice
to the courts under 44 U.S.C. 1503 & 1507.
Learn more here.
Published Document: 2012-1887 (77 FR 4568)
This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice of public conference.
SUMMARY:
The Food and Drug Administration (FDA), in cosponsorship with the Pharmaceutical Users Software Exchange (PhUSE), is announcing a public conference entitled “The FDA/PhUSE Annual Computational Science Symposium.” The purpose of the conference is to help the broader community align and share experiences to advance computational science. At the conference, which will bring together FDA, industry, and academia, FDA will update participants on current initiatives, and collaborative working groups will address specific challenges in accessing and reviewing data to support product development. These working groups will focus on solutions and practical ways to implement them.
DATES:
Date and Time:
The public conference will be held on March 19 and 20, 2012, from 9 a.m. to 4:30 p.m.
Location:
The public conference will be held at the Silver Spring Civic Building at Veterans Plaza, One Veterans Pl., Silver Spring, MD 20910, 1-(240)-777-5300.
Contact:
Chris Decker, U.S. Regional Director, Pharmaceutical Users Software Exchange (PhUSE), 64 High St., BROADSTAIRS CT10 1JT, United Kingdom, (202) 386-6722, e-mail:
office@phuse.eu.
SUPPLEMENTARY INFORMATION:
I. Working Groups and Their Areas of Focus
Six working groups will address particular challenges related to the access and review of data to support product development:
Working Group 1: Data Validation and Quality Assessment,
Working Group 2: Reducing Risk Within the Inspection Site Selection Process,
Working Group 3: Challenges of Integrating and Converting Data Across Studies,
Working Group 4: Standards Implementation Issues With the Clinical Data Interchange Standards Consortium Data Models,
Working Group 5: Development of Standard Scripts for Analysis and Programming, and
Working Group 6: “Non-Clinical Road-Map” and Impacts on Implementation.
A description of the planned activities of the working groups can be found at
http://www.phuse.eu/Working-Groups.aspx.
(FDA has verified the Web site addresses throughout this document, but FDA is not responsible for any subsequent changes to the Web sites after this document publishes in the
Federal Register
.)
II. Registration and Accommodations
A. Registration
To register, please submit the registration form online at
https://www.phuse.eu/PhUSE-Conference-2012-Registration.aspx.
Registration fees cover the cost of facilities, materials, and food functions. Seats are limited, and conference space will be filled in the order in which registrations are received. Onsite registration will be available to the extent that space is available on the day of the conference. The costs of registration for different categories of attendee are as follows:
Cost of Registration
Category
Cost
Industry representatives registering by January 15, 2012
$750
Industry representatives registering after January 15, 2012
950
Those with Government affiliation
300
Representatives of nonprofit organizations
600
Those attending for a single day
650
Government and nonprofit attendees and exhibitors will need an invitation code to register at the discounted rate. An invitation code can be obtained by sending an email to:
office@phuse.eu. All registrants will pay a fee with the exception of a limited number of speakers/organizers who will have a complimentary registration.
B. Accommodations
Attendees are responsible for their own accommodations. Attendees making reservations at the Courtyard by Marriott Silver Spring Downtown Hotel are eligible for a reduced conference rate of $199, not including applicable taxes. Those making reservations online should use the group code “SPRSPRB” to receive the special rate. If you need special accommodations because of disability, please contact Chris Decker (see
Contact) at least 7 days before the meeting.
III. Posters and Exhibits Information
Posters will be presented and may include demonstrations to provide an interactive experience. Although PhUSE welcomes demonstrations to support and explore the posters that are presented, neither PhUSE nor FDA endorse any commercial software or vendor. The creator of what is judged the best poster will be recognized and offered the opportunity to present the poster at the closing session.
Poster topics include:
Data submission standards development, implementation, and best practices;
User experience and evaluation of current processes and tools and their effects on organizational performance;
Needs and specifications for proposed new tools and processes;
Business processes driving the development of information systems; and
The effect of processes and tools on problem solving quality, efficiency, and cost.
( printed page 4569)